Atlas Trials

Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)

Clinical trial NCT02637960 · COMPLETED

Trial details

NCT number
NCT02637960
Sponsor
Vantia Ltd
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Nocturia
Start date
2016-03-01
Primary completion
2017-07-01
Enrollment
432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.